Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

Age at initiation of treatment and the type of biologic therapy prescribed effect the rate of drug survival among patients with psoriasis.

Discover a recent study that has provided valuable insights into the experiences of Latine patients living with moderate to ...

The study revealed that younger patients (16-24 years) with moderate-to-severe psoriasis were more likely to discontinue TNF ...

Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal patches and plaques). It affects about 2% of the population and is mediated ...

Higher cardiovascular health scores on Life’s Essential 8 were linked to a significantly lower risk for psoriasis in a large, ...

A doctor may prescribe injectable treatments, such as methotrexate, TNF-alpha inhibitors, or interleukin inhibitors, for moderate to severe psoriasis when other treatments don’t work.

Published results showed “Latine” patients with psoriasis in the U.S. have unique experiences with their disease and ...

Deucravacitinib significantly improved skin-related quality of life of patients with moderate to severe plaque psoriasis, ...

You can apply sunscreen to psoriasis plaques to prevent sunburn, but, if the plaques from psoriasis are inflamed or cracked ...

Many people with ongoing medical conditions experience more symptoms during the winter. Here's why, and what you can do.

These findings may offer more personalized treatment and prevention recommendations for patients with psoriasis.